Empowering an organization or community

In order for change to be effective, the organization, managers, and leaders need to provide resources and training necessary to be successful. In addition, it is important that all stakeholders feel they have a voice in the decision-making process. As discussed in this week’s resources, these strategies empower stakeholders to take action. You empower action when you provide both the tools and the structure necessary to enable change.
Reflect on what you know about utilizing rewards to facilitate change, motivate stakeholders, and address barriers to change.
Post a cohesive response based on your analysis and your professional experience. Be sure to discuss the following:
• Examine who in your organization or community you empower. Analyze how a manager or leader might engage “disempowered” stakeholders.
• Recall your participation in a major change. Analyze how you or your colleagues were empowered.
• Based on your experiences, examine the most significant barrier that prevents employees from accepting or participating in change. Outline how you, as a manager or leader, can mitigate the challenges such barriers impose.
• Outline the steps you will emphasize to empower stakeholders when important, much-needed change is unwelcomed.

Sample Solution

dvantages of polymeric nanoparticles include: [81, 82]
(1) improve the stability of any volatile pharmaceutical agents, simply and economically fabricated in large quantities by a huge number of methods, (2) they present a significant improvement over conventional oral and intravenous routes of administration in terms of efficiency and effectiveness, (3) delivers a higher concentration of pharmaceutical agent to the required location, (4) the selection of polymer and the capability of modifying drug release from polymeric nanoparticles have made them typical choice for cancer therapy, delivery of vaccines, contraceptives and delivery of targeted antibiotics and (5) Polymeric nanoparticles can be easily included into other activities related to drug delivery, such as tissue engineering.

In nanoparticles formulations wide variety of polymers can be used according to the nature of drug and usage. (i.e.) Biodegradable polymers for short term therapy (e.g. Chemotherapeutic agents) and non-biodegradable polymers for long term therapy (e.g. Vaccines) [83].
The PNPs are obtained from synthetic polymers, such as poly- Ɛ-caprolactone [84], poly-acrylamide [85] and polyacrylate [86], or natural polymers, e.g., Albumin [87], DNA[88], chitosan [88, 89] and gelatin [90].Based on in vivo behavior, PNPs may be classified as biodegradable, i.e., Poly (L-lactide) (PLA) [91], polyglycolide (PGA) [92], and non biodegradable, e.g. Polyurethane [93].

This question has been answered.

Get Answer
WeCreativez WhatsApp Support
Our customer support team is here to answer your questions. Ask us anything!
👋 Hi, Welcome to Compliant Papers.